STAT March 24, 2025
Brian Stanley, Michael Nguyen-Mason

It can fill in gaps left by government and major drug makers

Small, early-stage biotech startups are the heart of drug innovation in the U.S. Growing anti-competitive challenges threaten their work, but philanthropy may offer an avenue forward.

At the center of these challenges is the U.S. patent system and...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma / Biotech
Podcast: Perspectives and projections on the 2025 biotech landscape
Makary’s FDA Has Options In Industry Fight Over Weight Loss Drugs
Collective Health, Noom Health partner for weight management
Faster Cancer Drug Approvals Tied to Clinical Benefits
Skepticism Hangs Over Cancer Drugs Stuck With Accelerated Approval for Years

Share This Article